Belgium has a long history of excellent clinical research addressing a wide range of therapeutic domains thanks to a unique health ecosystem, the quality of the clinical centres and the real-life expertise of investigators. Clinical research refers to a multistakeholder landscape in which tracing its path can be a challenging task, in particular for SMEs willing to bring their new health innovations ultimately to the patients.
The increasing importance of data intelligence, the necessary emphasis on patient input, the trend towards more personalised therapeutic approaches all asks for new clinical trial setups and models, from the preparatory phase up to the follow-up.
During the event you will hear the voice of industry (biopharma, biotech and medtech), learn about the hospital’s perspective, and the position of the patient therein. In addition, you will be updated on a number of new trends in the clinical trial landscape.
Mark the afternoon (starting at 13:00) of 6 March in your agenda to attend this interactive day with key players and stakeholders in the Belgian biopharma ecosystem.
📢 Is your company a member of Flanders Vaccine? Register as flanders.bio member and enjoy the member discount.